CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 33 enrolled
Drug / intervention
Placebo +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04130633
NCT04130633Phase 1Completed
CompareCT.gov

Behavioral Pharmacology of THC and Alpha-pinene

Johns Hopkins University·interventional·Posted Oct 17, 2019·Updated May 22, 2025

In Brief

A Phase 1 clinical trial evaluating Placebo, THC, and 1 other intervention for THC and Alpha-pinene. Completed, enrolled 33 participants across 1 site.

Detailed Summary

This study will evaluate the pharmacokinetics and pharmacodynamics of vaporized alpha-pinene and THC administered via inhalation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTHC, Alpha-pinene
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 1CompletedFinished
2020202120222023202420252026
First PostedOct 17, 2019
Enrollment StartNov 5, 2020
Primary CompletionMar 8, 2024
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 6.7 years ago

Interventions

Placebodrug

Placebo vapor (distilled water)

THCdrug

Pure THC vapor

Alpha-Pinenedrug

Pure alpha-pinene vapor